The spinal cord is harder to access and study than even the brain. The challenges posed by its mobility and anatomical structure have made understanding exactly how it functions difficult.
FDA pushes cancer drug developers to include overall survival data more frequently
For years, the FDA has allowed progression-free survival to serve as both a primary and surrogate endpoint to support speedy new cancer drug approvals. But
November 1, 2023